Nasdaq auph.

Feb 28, 2022 · What happened. Shares of the autoimmune disease specialist Aurinia Pharmaceuticals (NASDAQ: AUPH) are poised for a tough session today. Ahead of the opening bell, the drugmaker's share price ... NASDAQ: AUPH Aurinia Pharmaceuticals. Market Cap. $1B. Today's Change (1.44%) $0.13. ... (AUPH 1.44%), a company focused on developing treatments for autoimmune diseases, saw its share price fall ...Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.NEW YORK, May 23, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that...

Anyone who held Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) over the last year knows what a loser feels like. The share price has slid 66% in that time. On the bright side, the stock is actually up 50%

EDMONTON, Alberta, June 29, 2023--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) ("Aurinia" or the "Company") today announced that its Board of Directors has initiated an exploration ...

Aurinia AUPH announced that it has acquired two new pipeline candidates, which will target rare autoimmune and kidney-related diseases. Both the candidates, renamed as AUR200 and AUR300 following ...8.82%. 141,687,578. 12,497,875. 1,990,667. 6.28. Data brought to you by Benzinga APIs. Looking for the most shorted stocks? Short interest for Aurinia Pharmaceuticals gives investors a sense of ...Last month, AUPH's second largest shareholder, MKT Capital, which holds 4.2% of the stock, wrote a scathing letter to shareholders, calling to withdraw support for CEO Peter Greenleaf, board ...In trading on Thursday, shares of Aurinia Pharmaceuticals Inc (Symbol: AUPH) crossed above their 200 day moving average of $8.57, changing hands as high as $8.92 per share. Aurinia Pharmaceuticals ...

These stocks are American Woodmark Corporation (NASDAQ:AMWD), Great Western Bancorp Inc (NYSE:GWB), SEMrush Holdings, Inc. (NYSE:SEMR), Aurinia Pharmaceuticals Inc (NASDAQ:AUPH), Addus Homecare ...

Nov. 20, 2023, 12:38 PM. Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares are trading higher, adding to gains of more than 17% over the last week. The stock has been trending higher since the ...

On November 2, 2023, Aurinia Pharmaceuticals Inc ( NASDAQ:AUPH) released its financial results for the third quarter and nine months ended September 30, 2023. The company reported a significant ...Anyone who held Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) over the last year knows what a loser feels like. The share price has slid 66% in that time. On the bright side, the stock is actually up 50%Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20)Nasdaq provides company’s , which are financial statements and reports filed electronically with the U.S. Securities and Exchange Commission (SEC) by Quotemedia. The SEC requires all publicly ... These stocks are American Woodmark Corporation (NASDAQ:AMWD), Great Western Bancorp Inc (NYSE:GWB), SEMrush Holdings, Inc. (NYSE:SEMR), Aurinia Pharmaceuticals Inc (NASDAQ:AUPH), Addus Homecare ...Zacks earnings numbers are reported on a BNRI (Before Non Recurring Items) basis and include stock option expenses where possible. Nasdaq provides visual representation of analyst expected ...Aurinia Pharmaceuticals Price Performance Shares of NASDAQ AUPH opened at $9.06 on Monday. The company has a current ratio of 5.77, a quick ratio of …

See the latest Aurinia Pharmaceuticals Inc stock price (AUPH:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Nov 30, 2023 · See the latest Aurinia Pharmaceuticals Inc stock price (AUPH:XNAS), related news, valuation, dividends and more to help you make your investing decisions. With the business potentially at an important milestone, we thought we'd take a closer look at Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) future prospects. Aurinia Pharmaceuticals Inc., a ...Nov 22, 2021 · Aurinia Pharmaceuticals ( NASDAQ: AUPH) has been on a roll this year since their second quarter earnings in August. The stock jumped from $10 to over $30, buoyed by strong uptake of voclosporin ... Nasdaq provides company’s , which are financial statements and reports filed electronically with the U.S. Securities and Exchange Commission (SEC) by Quotemedia. The SEC requires all publicly ...

Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.Sep 27, 2023 · It has been quite some time since we last took a look at Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH). This small biopharma has been somewhat of a roller coaster ride for its shareholders in recent ...

Aurinia Pharmaceuticals (NASDAQ:AUPH) Third Quarter 2022 ResultsKey Financial Results. Revenue: US$55.8m (up 280% from 3Q 2021). Net loss: US$8.99m (loss narrowed by 82% from 3Q 2021). US$0.063 ...About Latest Pre-Market Trades. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. December 4, 2023. Company. Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) has a beta value of 1.39 and has seen 0.72 million shares traded in the recent trading session. The company, currently valued at $1.27B, closed the recent trade at $8.82 per share which meant it lost -$0.24 on the day or -2.60% during that session.Zacks earnings numbers are reported on a BNRI (Before Non Recurring Items) basis and include stock option expenses where possible. Nasdaq provides visual representation of analyst expected ...Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has added two assets to expand its rare autoimmune and kidney-related disease pipeline. The first program, AUR200, was acquired from privately-held ...Last month, AUPH's second largest shareholder, MKT Capital, which holds 4.2% of the stock, wrote a scathing letter to shareholders, calling to withdraw support for CEO Peter Greenleaf, board ...Swiss National Bank raised its holdings in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 7.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).The firm owned 279,300 shares of the biotechnology company’s stock after acquiring an …Shares of Aurinia Pharmaceuticals Inc. AUPH gained 13.2% on Dec 2, following fresh rumors of a potential buyout. Reportedly, Swiss pharma giant Novartis NVS is looking out for small bolt-on ...

Aurinia Pharmaceuticals (NASDAQ:AUPH) is a biopharmaceutical firm delivering therapies for autoimmune, kidney, and rare diseases with unmet medical needs. In 2021, it introduced Lupkynis ...

December 4, 2023. Company. Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) has a beta value of 1.39 and has seen 0.72 million shares traded in the recent trading session. The company, currently valued at $1.27B, closed the recent trade at $8.82 per share which meant it lost -$0.24 on the day or -2.60% during that session.

NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that...ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) – Aurinia welcomes the 2023 updated recommendations from The European ...Financials. AUPH has a market cap of $1.3bn and a cash balance of $389mn. Research and development expenses were USD 9.9 million for 4Q. Selling, general and administrative expenses, inclusive of ...Aurinia Pharmaceuticals (NASDAQ: AUPH), in its third-quarter earnings call for 2023, reported a significant increase in net product revenue and ongoing expansion efforts, while also revealing that ...See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. AUPH's current price target is …Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Option Chain | Nasdaq. Call and put options are quoted in a table called a chain sheet. The chain sheet shows the price, volume and open interest ... Aurinia Pharmaceuticals Inc. NASDAQ: AUPH gapped up in heavy volume on the first trading day of the year and hasn’t looked back since. The Canadian biotech company launched LUPKYNIS two years ago as the first FDA-approved oral treatment for adults with active lupus nephritis (LN). This autoimmune disease affects more than …Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results Business Wire - Thu May 4, 5:00AM CDT. Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today issued its financial results for first quarter ended March 31, 2023. Amounts are expressed in U.S. dollars. 9.28.Aurinia Pharmaceuticals AUPH stock was up about 11% on Tuesday after the company announced that the United States Patent and Trademark Office (USPTO) issued a new and refined method-of-use patent ...

What happened. Shares of the autoimmune disease specialist Aurinia Pharmaceuticals (NASDAQ: AUPH) are poised for a tough session today. Ahead of the opening bell, the drugmaker's share price ...Find real-time AUPH - Aurinia Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Find real-time AUPH - Aurinia Pharmaceuticals Inc stock quotes,...See historical performance and comparison. View Valuation. Research Aurinia Pharmaceuticals' (Nasdaq:AUPH) stock price, latest news & stock analysis. Find …About Latest Pre-Market Trades. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.Instagram:https://instagram. vanguard technologyexcel finance coursenyse iotbest budget internet In trading on Monday, shares of Aurinia Pharmaceuticals Inc (Symbol: AUPH) entered into oversold territory, hitting an RSI reading of 28.7, after changing hands as low as $8.86 per share. By ...The new research reports from Fundamental Markets, available for free download at the links above, examine Shinhan Financial Group Co Ltd (NYSE:SHG), Aurinia Pharmaceuticals Inc (NASDAQ:AUPH ... tesla screen replacement costnyse arca bito VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on ...Aurinia Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. AUPH updated stock price target summary. madrigal pharmaceutical The latest price target for Aurinia Pharmaceuticals ( NASDAQ: AUPH) was reported by HC Wainwright & Co. on Friday, September 22, 2023. The analyst firm set a price target for 15.00 expecting AUPH ...Back to AUPH Overview. Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or ... Aurinia Pharma (NASDAQ: AUPH) shares quickly jumped to a session high, triggering a volatility halt after Bloomberg reported a potential bid from Bristol Myers Squibb (NYSE: BMY) to acquire the ...